RPS, GPhC issue joint statement on professional and regulatory standards


Share post:

All pharmacy owners, pharmacists and technicians are expected to be aware of and use all relevant standards, both regulatory and professional, to support them in their work.

The joint statement published by on Wednesday (June 15) by the Royal Pharmaceutical Society and General Pharmaceutical Council (GPhC) explains the difference between regulatory and professional standards and how they work together to provide a framework for professional practice and patient care.

It states: “All standards set by the GPhC work to improve the quality and safety of services provided to patients and the public. Regulatory standards must be met by all pharmacy professionals and owners of registered pharmacies, otherwise their registration may be at risk.

“Following professional and regulatory standards will help pharmacists, pharmacy technicians and pharmacy owners deliver patient-centred care and good quality outcomes and ensure that members of the public receive safe and effective care.”

The statement also highlighted that while professional standards and guidance are not mandatory, they are developed and owned by the profession and set out what constitutes ‘good’ in terms of practice, systems of care, and working practices.

“Pharmacy professionals following professional standards and guidance set by the RPS should have confidence these help to meet the overarching regulatory standards set by the GPhC,” the two bodies said.

RPS chief executive Paul Bennett commented: “As the professional leadership body for pharmacists, we support our members by providing professional guidance in all areas of practice that challenge and empower them to achieve excellence. Both regulatory and professional standards have the same overarching purpose, to ensure high quality patient care.”

Chief executive of the GPhC Duncan Rudkin added: “As the regulator, we expect all pharmacists, pharmacy technicians and pharmacy owners to be aware of and use all relevant standards, both regulatory and professional, to support them in their work. This helps make sure that patients and the public receive safe and effective care.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...